AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • February 23rd, 2022 • Eleison Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Amended and Restated Investor Rights Agreement (this “Agreement”), dated as of this 13th day of November, 2020, by and among Eleison Pharmaceuticals Inc., a Delaware corporation (the “Company”), BDI Co., Ltd., a joint stock company organized under the laws of the Republic of Korea (“BDI”), and those certain stockholders of the Company listed on Schedule A hereto. For purposes of this Agreement, “Investor” shall mean BDI, the Stockholders listed on Schedule A and any Investor that becomes a party to this Agreement in accordance with Section 6.9 hereof.
